Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Other Non-Current Liabilities: 2020-2023

Historic Other Non-Current Liabilities for Journey Medical (DERM) over the last 1 years, with Jun 2023 value amounting to $1.5 million.

  • Journey Medical's Other Non-Current Liabilities fell 60.87% to $1.5 million in Q2 2023 from the same period last year, while for Jun 2023 it was $1.5 million, marking a year-over-year decrease of 60.87%. This contributed to the annual value of $1.4 million for FY2022, which is 61.07% down from last year.
  • As of Q2 2023, Journey Medical's Other Non-Current Liabilities stood at $1.5 million, which was up 2.76% from $1.4 million recorded in Q1 2023.
  • Journey Medical's 5-year Other Non-Current Liabilities high stood at $8.1 million for Q4 2020, and its period low was $1.4 million during Q3 2022.
  • In the last 3 years, Journey Medical's Other Non-Current Liabilities had a median value of $2.6 million in 2021 and averaged $2.7 million.
  • Data for Journey Medical's Other Non-Current Liabilities shows a maximum YoY slumped of 68.52% (in 2022) over the last 5 years.
  • Quarterly analysis of 4 years shows Journey Medical's Other Non-Current Liabilities stood at $8.1 million in 2020, then slumped by 55.43% to $3.6 million in 2021, then crashed by 61.07% to $1.4 million in 2022, then crashed by 60.87% to $1.5 million in 2023.
  • Its Other Non-Current Liabilities was $1.5 million in Q2 2023, compared to $1.4 million in Q1 2023 and $1.4 million in Q4 2022.